Semaglutide
from $146/mo.

What Is Semaglutide?

Semaglutide is a GLP-1 receptor agonist — a synthetic version of a natural gut hormone called Glucagon-Like Peptide-1 (GLP-1). It was originally developed by Novo Nordisk and is the active ingredient in both Ozempic® (approved for Type 2 Diabetes) and Wegovy® (approved for chronic weight management).

Unlike natural GLP-1, which your body breaks down within minutes, semaglutide is engineered to resist degradation by the DPP-4 enzyme. This means a single weekly injection provides sustained appetite regulation, improved insulin sensitivity, and reduced "food noise" for a full 7 days.

In landmark clinical trials (STEP program), participants on semaglutide 2.4mg lost an average of 14.9% of body weight over 68 weeks — compared to just 2.4% with placebo. For a 220-pound individual, that's roughly 33 pounds of clinically meaningful weight loss.

How Semaglutide Works

Semaglutide mimics GLP-1 to act on multiple systems simultaneously:

• Appetite Suppression: Acts on the hypothalamus to dramatically reduce hunger signals and eliminate obsessive "food noise" — the constant mental fixation on eating that derails traditional diets.
• Delayed Gastric Emptying: Slows the rate at which food leaves your stomach, extending satiety after meals and naturally reducing portion sizes.
• Insulin Regulation: Stimulates glucose-dependent insulin secretion while suppressing glucagon, improving blood sugar control independent of weight loss.
• Cardiovascular Protection: The SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in overweight/obese adults — making semaglutide the first obesity medication to show heart-protective benefits.
• Metabolic Reset: By reducing caloric intake and improving insulin sensitivity simultaneously, semaglutide helps lower set-point weight — the body weight your metabolism actively defends.

Semaglutide Dosing & Titration Schedule

Semaglutide is administered as a once-weekly subcutaneous injection, typically in the abdomen, thigh, or upper arm. The standard titration schedule gradually increases the dose to minimize side effects:

Your Telehealth FX clinician will personalize this schedule based on your response and tolerance. Some patients achieve excellent results at lower maintenance doses.

Clinical Evidence & Trial Results

Semaglutide has one of the strongest evidence bases of any weight loss medication in history:

• STEP 1 (2021): 1,961 adults without diabetes lost an average of 14.9% body weight over 68 weeks vs. 2.4% with placebo. One-third of participants lost ≥20% of body weight.
• STEP 2 (2021): In adults with Type 2 Diabetes, semaglutide 2.4mg produced 9.6% weight loss vs. 3.4% placebo, with significant HbA1c improvements.
• STEP 3 (2021): Combined with intensive behavioral therapy, participants lost 16.0% of body weight — demonstrating the power of medication + lifestyle changes.
• STEP 5 (2022): Over 2 years of continuous treatment, participants maintained 15.2% weight loss — proving sustained efficacy.
• SELECT (2023): In 17,604 overweight/obese adults with cardiovascular disease, semaglutide reduced major adverse cardiovascular events by 20% — a landmark finding that expanded its clinical significance beyond weight loss.

What Is Compounded Semaglutide?

Compounded semaglutide contains the same active ingredient as branded Ozempic and Wegovy, but is produced by licensed 503A and 503B compounding pharmacies in the United States. These pharmacies operate under FDA oversight and follow Current Good Manufacturing Practices (cGMP).

The key difference? Price. Branded Wegovy costs $1,300+/month without insurance. Compounded semaglutide through Telehealth FX starts at $146/month — making this clinically proven treatment accessible to people who would otherwise be priced out of the most effective weight loss medication available.

Every compounded prescription is:

• Prescribed by a licensed, board-certified clinician after medical review
• Compounded by a licensed US pharmacy under FDA oversight
• Shipped via 2-day UPS with cold-chain packaging when required
• Accompanied by a 1-on-1 onboarding call with your care team

Side Effects & Safety Profile

The most common side effects are gastrointestinal and typically improve as your body adjusts during the titration period:

• Nausea (most common, usually mild-moderate, improves over weeks)
• Diarrhea or constipation
• Injection site reactions (mild redness, itching)
• Fatigue or headache (typically transient during titration)

Serious side effects are rare but can include pancreatitis, gallbladder issues, and hypoglycemia (particularly when combined with insulin or sulfonylureas). Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Your Telehealth FX clinician will screen for contraindications during your initial assessment and provide ongoing monitoring throughout treatment.

Who Is a Good Candidate for Semaglutide?

Semaglutide may be appropriate for adults who meet the following criteria:

• BMI ≥ 30 (obesity), or BMI ≥ 27 with at least one weight-related condition (hypertension, Type 2 Diabetes, high cholesterol, sleep apnea)
• Adults who have struggled with traditional diet and exercise approaches
• Individuals seeking clinically meaningful weight loss (10-20%+ of body weight)
• Patients looking for cardiovascular risk reduction alongside weight management

Semaglutide vs. Tirzepatide: Which Is Right for You?

Both medications are highly effective. Your clinician will recommend the best option based on your medical history, goals, and budget. Many patients start with semaglutide and transition to tirzepatide if additional weight loss is desired.

How the Telehealth FX Semaglutide Program Works

Frequently Asked Questions